Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 3 16-3, 1997, Pages

  Boros, Veronika ^a,b   Burghardt, Jacqueline S ^a   Morgan, Catherine J ^a   Olson, David M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ST JOHN'S HOSPITAL   (Hungary)

Author keywords

bronchopulmonary dysplasia; MK 0591; morphometry; oxygen toxicity; Wy 50295

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ALPHA METHYL 6 (2 QUINOLYLMETHOXY) 2 NAPHTHYLACETIC ACID; LEUKOTRIENE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG TOXICITY; MALE; MORPHOMETRICS; NEWBORN; NONHUMAN; OXYGEN TOXICITY; PRIORITY JOURNAL; RAT;

EID: 0030912041     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.3.l433     Document Type: Article

References (38)

1. Briedeau, C., C. Chan, S. Charleson, D. Denis, J. F. Evans, A. W. Ford-Hutchinson, J. W. Gillard, J. Guay, and D. Guevermont. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthiol-5-(quinolin-2yl-methoxy)-indol-2-yl]-2,2- dimethylpropanoic acid) a potent, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 70: 799-807, 1992.
2. Bruce, M. C., R. Pavlowski, and J. F. Tomashefski. Changes in lung elastic fiber structure and concentration associated with hyperoxia in the developing rat lung. Am. Rev. Respir. Dis. 140: 1067-1074, 1989.
3. Bucher, J. R., and R. J. Roberts. The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation and changes in antioxidant enzyme activites. Pediatr. Res. 15: 999-1008, 1981.
4. Burghardt, J. S., V. Boros, D. F. Biggs, and D. M. Olson. Lipid mediators in oxygen-induced airway remodeling and hyperresponsiveness in newborn rats. Am. J. Respir. Crit. Care Med. 154: 837-842, 1996.
5. Burghuber, O. C., R. J. Strife, J. Zirolli, P. M. Henson, M. M. Mathias, J. T. Reevers, R. C. Murphy, and N. F. Voelkel. Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. Am. Rev. Respir. Dis. 131: 778-785, 1985.
6. Clark, J. M., and C. J. Lambersten. Pulmonary oxygen toxicity. Pharmacol. Rev. 23: 37-133, 1971.
7. Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arforst, S. Hammarstrom, J. A. Lindgren, and B. Samuelsson. Leukotrienes promote plasma leakage and leukocyte adhesion in post capillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78: 3883-3891, 1981.
8. Dethlefsen, S. M., D. Shepro, and P. A. D'Amore. Arachidonic acid metabolites in bFGF-, PDGF- and serum-stimulated vascular cell growth. Exp. Cell Res. 212: 263-273, 1994.
9. Diamant, Z., M. C. Timmers, H. VanderVeen, B. S. Friedman, M. DeSmet, M. Dupre, D. Hilliard, E. Bel, and P. J. Stark. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J. Allergy Clin. Immunol. 95: 42-51, 1995.
10. Downs, T. R., and W. W. Wilfinger. Fluorometric quantification of DNA in cells and tissue. Anal. Biochem. 131: 538-547, 1983.
11. Eronen, M., E. Pesonen, T. Kurki, K. Teramo, O. Ylikorkala, and M. Hallman. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J. Pediatr. 124: 782-788, 1994.
12. 2 exposure. Pediatr. Res. 21: 109-115, 1987.
13. Frank, L., and G. E. McLaughlin. Protection against acute and chronic hyperoxic inhibition of neonatal rat lung development with the 21-aminosteroid drug, U74389F. Pediatr. Res. 33: 623-638, 1993.
14. Groneck, P., B. Goetze-Speer, M. Opperman, H. Effert, and C. P. Speer. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93: 712-718, 1994.
15. Gross, L., G. Walker, W. Smith, M. Maniscalo, M. Czajka, C. Wilson, and S. Rooney. An organ culture model for studying biochemical development of fetal rat lung. J. Appl. Physiol. 75: 355-360, 1978.
16. Gurtner, G. H., I. S. Farrukh, N. F. Adkinson, A. M. Sciuto, J. M. Jacobson, and J. R. Michale. The role of arachidonate mediators in peroxide-induced lung injury. Am. Rev. Respir. Dis. 136: 480-483, 1987.
17. Hageman, J. R., J. Zemaitis, R. B. Holtzman, S. E. Smith, and C. E. Hunt. Failure of non-selective inhibition of arachidonic acid metabolism to ameliorate hyperoxic lung injury. Prost. Leuko. Essent. Fatty Acids 32: 145-153, 1988.
18. 4. Acta Physiol. Scand. 110: 331-333, 1980.
19. Hogaboam, C. M., D. Donigi-Gale, T. S. Shoupe, E. Y. Bissonnette, A. D. Befus, and J. L. Wallace. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Br. J. Pharmacol. 105: 87-92, 1992.
20. Leikauff, G. D., H. E. Claesson, C. A. Doupnik, S. Hybinette, and R. C. Grafstrom. Cysteinyl leukotrienes enhance growth of human airway epithelial cells. Am. J. Physiol. 259 (Lung Cell. Mol. Biol. 3): L255-L261, 1990.
21. Margraf, L. R., J. F. Tomashefski, Jr., M. C. Bruce, and B. B. Dahms. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 143: 391-400, 1991.
22. Massaro, D., N. Teich, S. Maxwell, G. Massaro, and P. Whitney. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J. Clin. Invest. 76: 1297-1305, 1985.
23. 2 and a critical period. Am. J. Physiol. 258 (Lung Cell. Mol. Physiol. 2): L321-L327, 1990.
24. Massaro, G. D., and D. Massaro. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L305-L310, 1996.
25. Menard, L., M. Laviolette, and P. Borgeat. Studies of the inhibitory activity of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthiol-5-(quinolin-2yl-methoxy)-indol-2-yl]-2,2- dimethylpropanoic acid) on arachidonic acid metabolism in human phagocytes. Can. J. Physiol. Pharmacol. 70: 808-813, 1992.
26. Musser, J. H., and A. F. Kreft. 5-lipoxygenase: properties, pharmacology, and the quinolinyl (bridged) aryl class of inhibitors. J. Med. Chem. 35: 2501-2524, 1992.
27. Nagai, A., M. Katayama, W. M. Thurlbeck, R. Matsui, S. Yasui, and K. Konno. Effect of indomethacin on lung development in postnatal rats: possible role of prostaglandins in alveolar formation. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L56-L62, 1995.
28. Parente, L., M. Fitzgerald, G. DeNucci, and S. Moncada. The release of lyso-PAF from guinea-pig lungs. Eur. J. Pharmacol. 112: 281-284, 1985.
29. 4: a role for mediation of interleukin 1. Atherosclerosis 113: 11-18, 1995.
30. Randell, S. H., R. R. Mercer, and S. L. Young. Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40 day old rats. Am. J. Pathol. 136: 1259-1266, 1990.
31. Scherle, W. F. A simple method for volumetry of organs in quantitative stereology. Mikroscopie 26: 57-60, 1970.
32. Stenmark, K. R., M. Eyzaguire, J. Y. Westcott, P. M. Henson, and R. C. Murphy. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 136: 770-772, 1987.
33. Suen, H. C., K. D. Bloch, and P. K. Donahoe. Antenatal glucocorticoid corrects pulmonary immaturity in experimentally-induced congenitally diaphragmatic hernia in rats. Pediatr. Res. 35: 523-529, 1994.
34. 4 in the genesis of oxygen toxicity in the lung. Am. Rev. Respir. Dis. 133: 805-808, 1986.
35. Thibeault, D. W., S. Mabry, and M. Rezaiekhaligh. Neonatal pulmonary oxygen toxicity in the rat lung changes with aging. Pediatr. Pulmonol. 9: 96-108, 1990.
36. Weibel, E. R. Morphometry of the Human Lung. Berlin: Springer, 1963, p. 151.
37. Yam, J., L. Frank, and R. J. Roberts. Oxygen toxicity: comparison of lung biochemical responses in neonatal and adult rats. Pediatr. Res. 12: 115-119, 1978.
38. Zweir, J. L. Electron paramagnetic response evidence that cellular toxicity is caused by the generation of superoxide and hydroxyl free radical. FEBS Lett. 252: 12-16, 1989.